Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin αvβ5 Signaling Pathway

Convallatoxin Promotes M2 Macrophage Polarization to Attenuate Atherosclerosis Through PPARγ-Integrin αvβ5 Signaling Pathway

Yi Zhang,1 Xiujin Shi,1 Jialun Han,1 Wenxing Peng,1 Zhenwei Fang,1 Yang Zhou,1 Xiaoyu Xu,1 Jie Lin,2,3 Fucheng Xiao,4 Limin Zhao,3 Yang Lin1 1Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, People’s Republic of China; 2Department of Endocrinolo...

Full description

Bibliographic Details
Main Authors:	Zhang Y, Shi X, Han J, Peng W, Fang Z, Zhou Y, Xu X, Lin J, Xiao F, Zhao L, Lin Y
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-02-01
Series:	Drug Design, Development and Therapy
Subjects:	atherosclerosis convallatoxin macrophage polarization ox-ldl pparγ-integrin αvβ5 signaling pathway
Online Access:	https://www.dovepress.com/convallatoxin-promotes-m2-macrophage-polarization-to-attenuate-atheros-peer-reviewed-article-DDDT

Similar Items

The cardiac glycoside convallatoxin inhibits the growth of colorectal cancer cells in a p53-independent manner
by: Sarah E. Anderson, et al.
Published: (2017-12-01)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
by: Dongliang Fang, et al.
Published: (2022-01-01)

Convallatoxin, the primary cardiac glycoside in lily of the valley (Convallaria majalis), induces tissue factor expression in endothelial cells
by: Mami Morimoto, et al.
Published: (2021-11-01)

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
by: Yuji Nakano, et al.
Published: (2020-07-01)

Electronegative LDL Is Associated with Plaque Vulnerability in Patients with Ischemic Stroke and Carotid Atherosclerosis
by: Núria Puig, et al.
Published: (2023-02-01)

LOX-1: Regulation, Signaling and Its Role in Atherosclerosis
by: Ajoe John Kattoor, et al.
Published: (2019-07-01)

PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01)

TGF-β Isoforms and GDF-15 in the Development and Progression of Atherosclerosis
by: Agnė Liuizė (Abramavičiūtė), et al.
Published: (2024-02-01)

Dan-Lou Prescription Inhibits Foam Cell Formation Induced by ox-LDL via the TLR4/NF-κB and PPARγ Signaling Pathways
by: Li-Na Gao, et al.
Published: (2018-05-01)

A reduction of Syndecan-4 in macrophages promotes atherosclerosis by aggravating the proinflammatory capacity of macrophages
by: Jiaxin Hu, et al.
Published: (2022-07-01)

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels
by: Erbel C, et al.
Published: (2011-08-01)

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
by: Q. Dong, et al.
Published: (2013-09-01)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
by: Zhiwen Wang, et al.
Published: (2022-03-01)

Isoborneol Attenuates Low-Density Lipoprotein Accumulation and Foam Cell Formation in Macrophages
by: Wang Y, et al.
Published: (2020-01-01)

Natural products in atherosclerosis therapy by targeting PPARs: a review focusing on lipid metabolism and inflammation
by: Yan Zhang, et al.
Published: (2024-04-01)

P62 Links the Autophagy Pathway and the Ubiquitin–Proteasome System in Endothelial Cells during Atherosclerosis
by: SeJeong Kim, et al.
Published: (2021-07-01)

The Role of PPAR and Its Cross-Talk with CAR and LXR in Obesity and Atherosclerosis
by: Pengfei Xu, et al.
Published: (2018-04-01)

Studies on the contribution of PPAR Gamma to tuberculosis physiopathology
by: Ariana Díaz, et al.
Published: (2023-04-01)

lncRNA GAPLINC regulates vascular endothelial cell apoptosis in atherosclerosis
by: Jun Pan, et al.
Published: (2023-07-01)

Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis
by: Anastasia V. Poznyak, et al.
Published: (2021-01-01)

The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators
by: Liqin Yin, et al.
Published: (2022-03-01)

PPAR-γ gene expression in pericoronary adipose tissue: A focus on obesity
by: Maria Marketou, et al.
Published: (2023-01-01)

The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers
by: Alessandro Scalia, et al.
Published: (2023-06-01)

PPAR𝛾 gene and atherosclerosis: Genetic polymorphisms, epigenetics and therapeutic implications
by: Grbić E, et al.
Published: (2018-10-01)

PPARγ in Atherosclerotic Endothelial Dysfunction: Regulatory Compounds and PTMs
by: Jinwen Luan, et al.
Published: (2023-09-01)

Determining effects of elaidic acid on PPAR- gamma expression in RAW 264.7 macrophage cell line
by: Montakhab Yegane H, et al.
Published: (2012-08-01)

Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity
by: Shi Feng, et al.
Published: (2016-09-01)

The effect of ox-LDL and platelets on macrophages, M2 macrophage polarization, and foam cell formation
by: Fatemeh Barati, et al.
Published: (2023-01-01)

Resveratrol Suppresses Oxidised Low-Density Lipoprotein-Induced Macrophage Apoptosis through Inhibition of Intracellular Reactive Oxygen Species Generation, LOX-1, and the p38 MAPK Pathway
by: Rong Guo, et al.
Published: (2014-08-01)

Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL
by: Baocai Wang, et al.
Published: (2017-04-01)

Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis
by: Preusch MR, et al.
Published: (2016-08-01)

The Role of PPARγ Gene Polymorphisms, Gut Microbiota in Type 2 Diabetes: Current Progress and Future Prospects
by: Zhao YK, et al.
Published: (2023-11-01)

The in vitro Effect of Oxidized LDL and PHA on Proliferation and Gene Expression of Regulatory T Cells in Patients with Atherosclerosis
by: Azadeh Mottaghi, et al.
Published: (2012-09-01)

Inclisiran inhibits oxidized low-density lipoprotein-induced foam cell formation in Raw264.7 macrophages via activating the PPARγ pathway
by: Zhaoping Wang, et al.
Published: (2022-05-01)

The crosstalk of ABCA1 and ANXA1: a potential mechanism for protection against atherosclerosis
by: Xin Shen, et al.
Published: (2020-09-01)

The Placebo-Controlled Effect of Percutaneous Coronary Intervention on Exercise Induced Changes in Anti-Malondialdehyde-LDL Antibody Levels in Stable Coronary Artery Disease: A Substudy of the ORBITA Trial
by: Adam Hartley, et al.
Published: (2021-10-01)

LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis
by: Dimitry A. Chistiakov, et al.
Published: (2016-05-01)

Serum ox-LDL Level is Reduced with the Extent of Stenosis in Coronary Arteries
by: Mohammad Najafi, et al.
Published: (2013-05-01)

Hydroxysafflor yellow A inhibits endothelial cell ferroptosis in diabetic atherosclerosis mice by regulating miR-429/SLC7A11
by: Jianjie Rong, et al.
Published: (2023-12-01)

PACAP regulates VPAC1 expression, inflammatory processes and lipid homeostasis in M1- and M2-macrophages
by: Roman Witzel, et al.
Published: (2023-10-01)